Topics: COVID-19
Events
-
-
AAHMS webinar – COVID-19: Where to from here?
-
Tweetchats with PRAXIS and ACTA
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
-
Best Practice Guidance for Clinical Trial Sites in COVID-19: Consolidating the information
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
News
-
New South Wales Office for Health and Medical Research COVID-19 Guidance
-
Australian Commission on Safety and Quality in Health Care extends timeline for National Clinical Trials Governance Pilot due to COVID-19 pandemic
-
PRAXIS Managing Clinical Trials webinar recording now available
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
ARCS Webinar Series: COVID-19: considerations and strategies for running trials during the pandemic
-
ClinTrial Refer COVID-19 app access
-
JAMA recommendations on maintaining clinical trial integrity during COVID-19 pandemic
-
ACTA statement on COVID-19
-
NSW Health COVID-19 Research Grants
-
Symposium: Social and ethical implications of the COVID-19 pandemic
-
COVID-19: Guidance on Australian clinical trials for institutions, HRECs, researchers and sponsors
-
NHMRC seeks experts to assess COVID-19 grant applications
-
Survey: Cochrane COVID-19 Core Outcome Set Project
-
The Lancet COVID-19 Resource Centre
-
Tweetchats with PRAXIS and ACTA
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
MHRA guidance on managing clinical trials during Coronavirus (COVID19)
-
Australian Research Council extensions due to COVID-19 impact on researchers
-
The US Food and Drug Administration (FDA) guidance on conduct of clinical trials of medical products during COVID-19 pandemic was updated 27 March 2020
-
COVID-19 and clinical trial updates
-
Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry
-
PRAXIS Webinar Managing clinical trials in a time of uncertainty: COVID-19
-
Medical Research Future Fund COVID 19 funding
-
National COVID-19 Clinical Evidence Taskforce: New Clinical Guidelines for COVID-19 to help Australian clinicians deliver best care